CompletedNot applicableNCT02684123

Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Icahn School of Medicine at Mount Sinai
Principal Investigator
Emma Guttman, MD, PhD
ISMMS
Intervention
Apremilast(drug)
Enrollment
30 target
Eligibility
18 years · All sexes
Timeline
20162017

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02684123 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials